occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A MONTELUKAST MESALAMINE MITOXANTRONE HYDROCHLORIDE FLUOXETINE PENTAMIDINE TRASTUZUMAB VALDECOXIB VARDENAFIL secondary progressive multiple sclerosis pneumocystosis bulimia nervosa breast cancer impotence asthma osteoarthritis chronic myeloid leukemia ulcerative colitis Child Adult respiratory system inflammation AE sinusitis AE 10040753 SS, YH, RR CTCAE: E11563 According to the Vaccine Adverse Event Reporting System (VAERS), 'sinusitis'; is an adverse event that was mentioned in 298 VAERS reports (0.2%) during1991-2001 (Reference: PMID: 12825543). SIDER: C0037199 NCIt: C35024 MP: MP_0001872 WEB: http://en.wikipedia.org/wiki/Sinusitis a respiratory system inflammation AE which has an outcome of sinus inflammation, an inflammation of paranasal sinuses, which may be due to infection, allergy, or autoimmune issues. sinus inflammation AE HPO: HP_0000246 AE severity G2 AE severity G3 AE severity G4 AE severity G5